Literature DB >> 20935306

Evaluation of factors influencing distance stereoacuity on Frisby-Davis Distance Test (FD2) in intermittent exotropia.

Rohit Saxena1, Ashish Kakkar, Vimla Menon, Pradeep Sharma, Swati Phuljhele.   

Abstract

AIM: To evaluate the factors affecting the restoration of stereoacuity after surgery in cases of intermittent exotropia.
METHODS: Thirty consecutive patients of intermittent exotropia X (T) scheduled for surgical intervention underwent preoperative evaluation, including complete ophthalmic and orthoptic examination. Deviation was measured for near and distance. Near stereo acuity was measured by The Netherland Organization stereotest (TNO), and distance stereo acuity was measured using the Frisby-Davis Distance (FD2) stereotest at 6 m for all cases and age-matched controls. All cases of X (T) were followed postoperatively at 1 week, 1 month, 3 months and 6 months.
RESULTS: Successful surgical alignment, defined as alignment within eight prism dioptres of exophoria, was seen in 84% of cases. The median distance stereo acuity improved from preoperative value of 50 s of arc to 17.5 s of arc, and near stereoacuity improved from 240 s of arc to 90 s of arc at 6 months postoperatively. The median distance and near stereo acuity in controls were 15 and 60 s of arc respectively. There was a significant difference in both distance and near stereoacuity between controls and cases, even after surgery. A high grade of preoperative stereoacuity was found to be a significant factor in determining the achievement of normal stereoacuity postoperatively. Age and amount of pre- and postoperative deviation were not found to have any affect. None of the above-mentioned factors had any influence on successful postoperative surgical correction.
CONCLUSION: There is a significant improvement in both near and distant stereoacuity postoperatively in X (T); however, the achievement of normal level depends upon the preoperative sensory status of the patient.

Entities:  

Mesh:

Year:  2010        PMID: 20935306     DOI: 10.1136/bjo.2010.182139

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

Review 1.  Stereo vision and strabismus.

Authors:  J C A Read
Journal:  Eye (Lond)       Date:  2014-12-05       Impact factor: 3.775

2.  The effects of simultaneous operation on dissociated vertical deviation with horizontal and torsional strabismus.

Authors:  Lu-Qin Wan; Xiao-Mei Wan; Hua-Qing Gong; Li-Xin Xie
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

3.  Can Clinical Measures of Postoperative Binocular Function Predict the Long-Term Stability of Postoperative Alignment in Intermittent Exotropia?

Authors:  Yidong Wu; Meiping Xu; Junxiao Zhang; Jinjing Zhou; Minghui Wan; Zhiyue Dai; Tingting Peng; Seung Hyun Min; Fang Hou; Jiawei Zhou; Xinping Yu
Journal:  J Ophthalmol       Date:  2020-07-21       Impact factor: 1.909

Review 4.  Development of a core outcome set for amblyopia, strabismus and ocular motility disorders: a review to identify outcome measures.

Authors:  Samia Al Jabri; Jamie Kirkham; Fiona J Rowe
Journal:  BMC Ophthalmol       Date:  2019-02-08       Impact factor: 2.209

5.  Model of a Support Vector Machine to Assess the Functional Cure for Surgery of Intermittent Exotropia.

Authors:  Yanli Liu; Chungao Liu; Wei Zhang; Xia Chen; Kanxing Zhao
Journal:  Sci Rep       Date:  2019-06-06       Impact factor: 4.379

6.  Distance stereotesting using vision test charts for intermittent exotropia.

Authors:  Noriko Nishikawa; Satoshi Ishiko; Ikuko Yamaga; Miho Sato; Akitoshi Yoshida
Journal:  Clin Ophthalmol       Date:  2015-08-25

7.  Stereoacuity with Frisby and revised FD2 stereo tests.

Authors:  Iwo Bohr; Jenny C A Read
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

8.  Evaluating stereoacuity with 3D shutter glasses technology.

Authors:  Huang Wu; Han Jin; Ying Sun; Yang Wang; Min Ge; Yang Chen; Yunfeng Chi
Journal:  BMC Ophthalmol       Date:  2016-04-26       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.